Hourglass Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Hourglass Capital's AMGN Position: Q1 2026 in Review
Hourglass Capital sold out of Amgen (AMGN) in Q1 2026, closing a stake of 1,347 shares — an estimated $441K sold.
Hourglass Capital first reported a position in AMGN in Q3 2018 and held it in 26 quarters. The position peaked at $441K in Q4 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Hourglass Capital reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
- Hourglass Capital sold 1,347 Amgen shares in Q1 2026, an estimated $441K.
- Hourglass Capital first reported a position in Amgen in Q3 2018 and held it in 26 quarters.
- Hourglass Capital's Amgen position peaked at $441K in Q4 2025.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Hourglass Capital's 13F filing for Q1 2026, filed 4 May 2026.